阿奇霉素序贯治疗儿童社区获得性肺炎的最小成本分析  

Cost Minimization Analysis of Sequential Treatment of Children Community-acquired Pneumonia with Azithromycin

作　　者：郑琳琴[1] 赵锋[1] 林响[1] 

机构地区：[1]福州市第二医院儿科,福州350007

出　　处：《药物流行病学杂志》2007年第1期43-45,共3页Chinese Journal of Pharmacoepidemiology

摘　　要：目的:评价阿奇霉素序贯治疗儿童社区获得性肺炎(CAP)的疗效及成本。方法:将118例CAP患儿随机分为阿奇霉素序贯治疗组(A组)和头胞他啶静脉注射治疗组(B组),观察临床治疗效果并作最小成本分析。结果:A组与B组总成本分别为(612±7．3)元、(819±8．2)元(P<0．05),疗效为91．94％,82．14％(P>0．05)。结论:阿奇霉素序贯治疗是治疗儿童CAP的较佳方案。Objective： To： investigate the curative effects and cost of sequential treatment of children community- acquired pneumoni（CAP） with azithromycin. Method： 118 cases of CAP from this hospital were divided into two groups： sequential azithromycin therapeutic group （Group A） and iv ceftazidime group （Group B）. Their clinical effect was observed and cost minimization analysis was carried out. Result： The total costs were 612 ± 7.3 yuan and 819 ± 8.2 yuan（P 〈 0.05 ） and the effective rates were 91.94% and 82.14% （ P 〉 0.05 ） in Group A and Group B respectively. Conclusion： The sequential azithromycin scheme is a better one to treat CAP.

关 键 词：社区获得性肺炎 阿奇霉素 序贯疗法 最小成本分析 

分 类 号：F407.7[经济管理—产业经济]